Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05858034 · ClinicalTrials.gov registry record · NA

Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older

A NA study of HIV and Aging, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05858034 is a NA study of HIV and Aging that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 100 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05858034, a NA study of HIV and Aging, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).

Conditions Studied

Interventions

  • OTHER Customized activity plan
  • OTHER Customized nutrition plan

Study Locations (1)

North Carolina

  • Atrium Health Wake Forest Baptist - Winston-Salem

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-06-27
Est. Completion 2027-02
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05858034

The ClinicalTrials.gov registry entry for NCT05858034 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (77% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which Customized activity plan is the first listed.

NCT05858034 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05858034 about?

NCT05858034 is a clinical study titled "Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older". The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).

What is the current status of trial NCT05858034?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-06-27. Estimated completion is 2027-02.

What conditions does trial NCT05858034 study?

This clinical trial studies the following conditions: HIV, Aging.

What interventions are being tested in trial NCT05858034?

The interventions under investigation include: Customized activity plan (OTHER), Customized nutrition plan (OTHER).

Who is sponsoring clinical trial NCT05858034?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05858034 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.